The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome
Abstract
Low-dose dexamethasone suppression testing has been recommended for biochemical screening when Cushing's syndrome is suspected. The criterion for normal suppression of cortisol after dexamethasone is controversial. To assess diagnostic utility (sensitivity), we report the results of low-dose dexamethasone suppression testing in 103 patients with spontaneous Cushing's syndrome. There were 80 patients with Cushing's disease (78%), 13 with the ectopic ACTH syndrome (13%), and 10 with cortisol-producing adrenocortical adenomas (10%). Fourteen (18%) of 80 patients with Cushing's disease suppressed serum cortisol to less than 5 micro g/dl (<135 nmol/liter) after the overnight 1-mg test, whereas six patients (8%) actually showed suppression of serum cortisol to less than 2 micro g/dl (<54 nmol/liter). In addition, the 2-d, low-dose dexamethasone suppression test yielded false-negative results in 38% of patients when urine cortisol was used and 28% when urinary 17-hydroxycorticosteroids were used. Serum cortisol after the 1-mg test correlated with baseline urinary free cortisol (r = 0.705, P < 0.001), plasma ACTH level (r = 0.322, P = 0.001), and urinary free cortisol after the 2-d test (r = 0.709, P = 0.001). This study provides evidence that low-dose dexamethasone may suppress either plasma cortisol or urinary steroids to levels previously thought to exclude Cushing's syndrome and that these tests should not be used as the sole criterion to exclude the diagnosis of endogenous hypercortisolism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Because some patients with Cushing's disease demonstrate suppressibility to dexamethasone, use of this diagnostic criterion misclassified up to 15% of such patients as negative (81,82).”
From The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. (2008) · cites this paper as [81]
In the citing paper
“Therefore, they may fail to detect cyclical CS during a low-cortisol phase (“off-cycle”) (a form of CS marked by intermittent cortisol excess) and may also yield normal or borderline results in patients with mild CS who have lower or fluctuating cortisol secretion (73, 90-93).”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [73]
Citations
Cites
Diagnosis and complications of Cushing’s syndrome: a consensus statement
Arnaldi, G., Angeli, A., Atkinson, A. B., Bertagna, X., Cavagnini, F., Chrousos, G. P., Fava, G. A., Findling, J. W., Gaillard, R. C., Grossman, A. B., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030871 · Cited by 1,362
Self-citationTauchmanovà, L., Rossi, R., Biondi, B., Pulcrano, M., Nuzzo, V., Palmieri, E.-A., Fazio, S., & Lombardi, G. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011766 · Cited by 400
Cushing's syndrome: a review of diagnostic tests.
Crapo, L. (1979) · Metabolism · doi:10.1016/0026-0495(79)90097-0 · Cited by 393
Diagnosis and Management of Cushing’s Syndrome: Results of an Italian Multicentre Study 1
Invitti, C., Giraldi, F. P., De Martin, M., & Cavagnini, F. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5465 · Cited by 336
Adrenal incidentaloma: a new cause of the metabolic syndrome?
Terzolo, M., Pia, A., Alì, A., Osella, G., Reimondo, G., Bovio, S., Daffara, F., Procopio, M., Paccotti, P., Borretta, G., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8277 · Cited by 322
The Cushing Syndrome: An Update on Diagnostic Tests
Kaye, T. B., & Crapo, L. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-3-112-6-434 · Cited by 310
Nighttime salivary cortisol: a useful test for the diagnosis of Cushing's syndrome.
Papanicolaou, D. A., Mullen, N., Kyrou, I., & Nieman, L. K. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020534 · Cited by 241
A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome
Newell‐Price, J., Trainer, P., Perry, L., Wass, J., Grossman, A., & Besser, M. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02918.x · Cited by 229
Aron, D. C. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.6.1780 · Cited by 226
Self-citation
Cited by
Items 101–164 of 164
Update on the Diagnosis of Cushing Syndrome
Liu, H., & Crapo, L. M. (2005) · The Endocrinologist · doi:10.1097/01.ten.0000162374.56442.ea · Cited by 9
Who and how to screen for endogenous hypercortisolism in patients with mood disorders
Ferrante, E., Simeoli, C., Mantovani, G., & Pivonello, R. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02457-5 · Cited by 10
Work up of Incidental Adrenal Mass: State of the Art
Bada, M., Castellan, P., Tamburro, F. R., Berardinelli, F., Neri, F., Cindolo, L., & Schips, L. (2016) · Urologia Journal · doi:10.5301/uro.5000176 · Cited by 8
“This has improved the sensitivity of the test (93-96%) (21).”
BackgroundMoszczyńska, E., Marczak, E., Szalecki, M., Kądziołka, K., Roszkowski, M., & Zagata-Lesnicka, P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.650967 · Cited by 8
Ye, D., Dong, F., Lu, X., Zhang, Z., Feng, Y., & Li, C. (2012) · Endocrine · doi:10.1007/s12020-011-9588-5 · Cited by 6
Update on the medical management of pituitary adenomas
Pickett, C. A. (2005) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-005-0045-9 · Cited by 6
“Recurrence rates appear to be higher (12.7% to 17%) when 24-hour urinary cortisol excretion on a low-dose dexamethasone suppression test is used to establish postoperative remission [17], and recent studies suggest that this test may produce falsenegative results in a substantial number of patients with untreated Cush…”
BackgroundInfluentialMojtahedzadeh, M., Shayesteh, N., Haykani, M., Tran, J., Mangubat, M., Shahinian, H. K., Nachnani, R., Zopey, M., Saidian, J., Thomas, A., et al. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0603-3868 · Cited by 6
“Findling and colleagues [31] reported that 18 % of patients with Cushing’s syndrome had a morning cortisol of < 135 nmol/l (4.”
Hayashi, L. F., Noguti, K. O., Nakamura, O. H., Kater, C. E., & Vieira, J. G. H. (2011) · Jornal Brasileiro de Patologia e Medicina Laboratorial · doi:10.1590/s1676-24442011000500003 · Cited by 6
“Pacientes com SC confirmada (n = 12) 449 ± 157 464 [174-661] 15,7 ± 7,9 15,9 [6,3-27,1]”
Prise en charge d’un hypercorticisme
Rosales, C., Fierrard, H., BERTAGNA, X. Y., & Raffin‐Sanson, M. (2008) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2007.11.007 · Cited by 8
Estrategias para el despistaje de la HTA secundaria
Galvañ, V. G., & Giner, M. J. E. (2006) · Hipertensión y Riesgo Vascular · doi:10.1016/s1889-1837(06)71658-0 · Cited by 6
Cameselle‐Teijeiro, J., Mato, J. A. M., Calvo, O. F., & Mata, J. G. (2018) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-018-0315-2 · Cited by 5
Advances in the Diagnosis and Medical Management of Cushing's Syndrome
Delivanis, D. A., Sharma, A. R., Hamidi, O., Shah, M., & Bancos, I. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-66195-9.00015-7 · Cited by 6
Findling, J. W., & Raff, H. (2016) · Springer eBooks · doi:10.1007/978-3-319-45950-9_6 · Cited by 4
Self-citationDing, L., Wang, B.-P., Chen, T.-T., Li, P., Guo, W., Fan, Y.-X., Fang, F., Cui, J., Dong, Z.-L., He, Q., et al. (2021) · Pituitary · doi:10.1007/s11102-021-01126-7 · Cited by 2
“Diagnosis of Cushing syndrome was based on clinical features and at least 2 of the following: (1) 24-h urinary free cortisol excretion (> 300 nmol/24 h) in at least 2 samples; (2) 1-mg overnight dexamethasone suppression test (0800 h plasma cortisol > 50 nmol/L) [6]; (3) 48 h, 2 mg/d dexamethasone suppression test uri…”
MethodDifferential diagnostics of adrenal incedentaloma
Kuznetsov, N. S., Beltsevich, D. G., Vanushko, V. E., Soldatova, T. V., Ремизов, О. В., Kats, L. E., & Lysenko, M. A. (2011) · Endocrine Surgery · doi:10.14341/2306-3513-2011-1-5-16 · Cited by 6
Sandner, B., & Kratzsch, J. (2017) · Journal of Laboratory Medicine · doi:10.1515/labmed-2017-0024 · Cited by 4
Cushing's disease: establishing the diagnosis and management approach.
Varadhan, L., Aror, A., Walker, A. B., & Varughese, G. I. (2013) · PubMed · Cited by 4
Endocrine Disturbances Affecting Reproduction
Chang, A. Y., & Auchus, R. J. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2758-2.00025-1 · Cited by 3
Dexamethasone-suppressed corticotropin-releasing hormone stimulation test in morbid obese adults
Saiegh, L., Keren, D., Rainis, T., Sheikh‐Ahmad, M., Reut, M., Nakhleh, A., Wirsansky, I., Chen‐Konak, L., Schiff, E., & Shechner, C. (2015) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2015.07.004 · Cited by 3
“[8] Findling JW, Raff H, Aron DC.”
BackgroundGas gangrene spreading to the bone marrow.
Janssen, E., den Ouden, H., van Herwaarden, J. A., Bollen, T. L., Geers, T., Wille, J. C., & de Vries, J.-P. (2006) · PubMed · Cited by 3
Karnath, B. M., & Ojo, O. B. (2008) · Cited by 3
Cortisol: mediciones de laboratorio y aplicación clínica
Hernandez-Quiceno, S., Uribe-Bojanini, E., Velásquez, J. M. A., Campuzano‐Maya, G., & Salazar-Peláez, L. M. (2016) · Medicina y Laboratorio · doi:10.36384/01232576.74 · Cited by 13
Endocrine Disturbances Affecting Reproduction
Chang, A. Y., & Auchus, R. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00024-x · Cited by 5
Hamidi, O., St-Jean, M., Lacroix, A., & Bancos, I. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag095 · Cited by 5
Sandner, B., & Kratzsch, J. (2017) · Journal of Laboratory Medicine · doi:10.1515/labmed-2017-0004 · Cited by 2
Balderrama-Soto, A., Rivera-Hernández, A. D. J., Reza-Albarrán, A. A., la Vega, A. N.-D., Vergara-López, A., Monteros-Sánchez, A. L. E. D. L., Navas-Minero, C. E., Abreu-Rosario, C., Ramos, D. C., Espinosa-Cárdenas, E., et al. (2023) · Revista Mexicana de Endocrinología Metabolismo y Nutrición · doi:10.24875/rme.m23000025 · Cited by 5
Tabarin, A., Collet, D., Galli, F. S., Maire, J.-P., & Loiseau, H. (2006) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(06)40170-0 · Cited by 3
Endocrine Disturbances Affecting Reproduction
Chang, A. Y., & Auchus, R. J. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4907-4.00023-1 · Cited by 2
Schäffler, A., Bollheimer, C., Büttner, R., Girlich, C., Aslanidis, C., Dietmaier, W., Bala, M., Guralnik, V., Karrasch, T., & Schneider, S. (2015) · Springer eBooks · doi:10.1007/978-3-662-47480-8_9 · Cited by 2
Adams, S. C., Guyot, C. M., Berry, K. M., Wallack, S. T., Loar, A. S., & Leblanc, M. (2017) · Europe PMC (PubMed Central) · Cited by 2
Jung, C., Derbyshire, M. M., Jauhar, N., Bennett, D., Topliss, D. J., Gogna, R., Markovic, N., Burgess, J. R., & Inder, W. J. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf188 · Cited by 2
“One of the limitations of our study was the use of different laboratories and assays in generating the retrospective CS and LPC data, which may compromise the precision that can be achieved using one methodology and measuring samples in the same batch [38].”
Cushing’s Disease and Syndrome
Lang, B. H., & Lo, C. (2009) · Springer eBooks · doi:10.1007/978-1-84628-881-4_28 · Cited by 1
Esfahanian, F., Faiz, F., Zamani, M. M., & Hantoushzadeh, S. (2012) · Galen Medical Journal · doi:10.31661/gmj.v1i1.10 · Cited by 1
“Regarding low-dose dexamethasone suppression test was suggested to be used to diagnose CS (8).”
MethodSchäffler, A., Bollheimer, C., Büttner, R., Girlich, C., Aslanidis, C., Dietmaier, W., Bala, M., Guralnik, V., Karrasch, T., & Schneider, S. (2018) · Springer eBooks · doi:10.1007/978-3-662-55914-7_9 · Cited by 1
Glucocorticoid-Induced Dose-Dependent Reproductive Impairments in Male Albino Rat
Patel, S., & Rai, S. (2023) · Journal of Endocrinology & Reproduction · doi:10.18311/jer/2023/34312 · Cited by 1
Kungpanichkul, N. (2010) · PubMed · Cited by 1
Kudo, M., Satoh, F., Aoki, S., Morimoto, R., Iwakura, Y., Ono, Y., Matsuda, K., Sugawara, A., Yoshida, K., Sato, K., et al. (2014) · Biomedicine & Aging Pathology · doi:10.1016/j.biomag.2014.04.001 · Cited by 3
Neuromuscular Manifestations of Acquired Metabolic, Endocrine, and Nutritional Disorders
Bassam, B. A., & Bertorini, T. E. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0372-6.00020-7 · Cited by 1
Cardiopatías de origen endocrino: una etiología frecuentemente olvidada
Duque-González, L., Ruíz, L. M., Torres-Grajales, J. L., & Duque-Ramírez, M. (2020) · Medicina y Laboratorio · doi:10.36384/01232576.298 · Cited by 4
“Para evaluar la presencia de hipercortisolismo se utilizan varios enfoques [21-23]:”
BackgroundHomologous Assay Development for Detection of Dexamethasone using HRP as Label Enzyme
Rangari, K., Kumar, D., Meena, R., Verma, D., & Shrivastav, T. G. (2023) · SSR Institute of International Journal of Life Sciences · doi:10.21276/ssr-iijls.2023.9.4.2 · Cited by 1
Cushing’s Disease: Diagnostic Evaluation
Findling, J. W., & Raff, H. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-264-9_10 · Cited by 1
Self-citationDiagnosis, Perioperative Care, and Remission in Cushing Disease
Thomas, A. J., Prevedello, D. M., Tomycz, N. D., Gardner, P. A., Challinor, S. M., Mintz, A. H., Horowitz, M., & Kassam, A. B. (2008) · Neurosurgery Quarterly · doi:10.1097/wnq.0b013e318173001b · Cited by 1
“One should be aware that patients with CD have been reported who suppressed below 2 mg/mL.(2) False-positive results (no suppression) can be seen with increased hepatic metabolism of dexamethasone (CYP3A4), which is common in patients taking drugs such as phenytoin and carbamazepine.”
BackgroundLow-dose dexamethasone suppression test: revisited
Kaltsas, G., & Besser, M. (2005) · Current Opinion in Internal Medicine · doi:10.1097/01.med.0000162076.72721.9d · Cited by 1
Auchus, R. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-385157-4.01207-0 · Cited by 1
Cushing's Syndrome : hormonal secretion patterns, treatment and outcome
van Aken, & Otto, M. (2005)
For information on reprint requests of more than 101 and commercial reprints contact
Barbour, L. A., Cobin, R. H., DeGroot, L. J., Glinoer, D., Mandel, S. J., & Edwards, H. A. (2008)
Newell-Price, J. D. C., BERTAGNA, X. Y., Grossman, A. B., & Nieman, L. K. (2006)
TRABAJOS ESPECIALES MANEJO DE PACIENTES CON SÍNDROME DE CUSHING.
Lima-Martínez, M. M., Zerpa, J., Guerrero, Y., Rivera, J., & Vielma, M. (2013)
Adrenal Cushing’s Syndrome: Updates on Overt and Mild Hypercortisolism
Escobar, J. S., Ravikumar, A., & Levine, A. C. (2017) · Contemporary Endocrinology · doi:10.1007/978-3-319-62470-9_10
Sinnvolle Anwendung endokrinologischer Tests
ChristCrain, M., Schild, U., & Müller, B. (2004) · Swiss Medical Forum ‒ Schweizerisches Medizin-Forum · doi:10.4414/smf.2004.05354
Cushing Syndrome; Screening and Differential Diagnosis
Lacroix, A., & Nieman, L. K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65857-9
A Stratified Approach for Cushing’s Syndrome Diagnosis
Chávez-Castillo, M., Rojas, J., Aguirre, M., Villalobos, M., Salazar, J. J., Bello, L., Áñez, R., Olivar, L. C., Calvo, M. C. C., Herazo-Beltrán, Y., et al. (2019) · Global Journal of Health Science · doi:10.5539/gjhs.v11n10p55
Balentine, C. J., & Sippel, R. S. (2015) · Springer eBooks · doi:10.1007/978-3-319-13662-2_35
Watanabe, M., & Yuta, K. (2009)
ACTH-Independent Cushing’s Syndrome: Adrenocortical Tumors
Fragoso, M. C. B. V., Domenice, S., Latronico, A. C., & Mendonca, B. B. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-449-4_16
Neuromuscular Manifestations of Acquired Metabolic, Endocrine, and Nutritional Disorders
Bassam, B. A., & Bertorini, T. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-71317-7.00021-4
Stewart, A. A., & Story, E. S. (2017) · Wiley eBooks · doi:10.1002/9781119196235.ch47 · Cited by 1
Borges, F. S. M., de Sá, L. S., Santos, R. D. S., Miranda, B. C. R., Lima, J. O. P. F., Prado, J. J. M., Braz, A. F., Barbosa, A. M., Neto, R. S. M., Vasconcelos, L. H. C., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1419641/v1
Schäffler, A., Bollheimer, C., Büttner, R., Girlich, C., Aslanidis, C., Dietmaier, W., Bala, M., Guralnik, V., Karrasch, T., & Wurm, S. (2012) · Springer eBooks · doi:10.1007/978-3-642-29690-1_9
Sinnvolle Anwendung endokrinologischer Tests
ChristCrain, M., Schild, U., & Müller, B. (2004) · Forum Médical Suisse ‒ Swiss Medical Forum · doi:10.4414/fms.2004.05354
Schäffler, A., Bollheimer, C., & Büttner, R. (2024) · Springer eBooks · doi:10.1007/978-3-662-68563-1_9
Schäffler, A., Bollheimer, C., & Büttner, R. (2024) · Springer eBooks · doi:10.1007/978-3-662-70260-4_9
Nonneoplastic hypercortisolism (pseudo-CS): Causes and long-term issues
Ferrière, A., & Tabarin, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-96100-4.00020-x · Cited by 1
Biologiczne i psychospoeczne czynniki związane z przebiegiem anoreksji u dziewcz ąt
Pytlińska, N. (2010) · Cited by 3
Metadata
- Authors
- Findling, J. W., Raff, H., & Aron, D. C.
- Affiliations
- Medical College of Wisconsin (US)
- Louis Stokes Cleveland VA Medical Center (US)
- Corresponding author
- Findling, James W.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-03
- Volume
- 89
- Issue
- 3
- Pages
- 1222-1226
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2165331817
- Semantic Scholar
- cffdec9ae0a9b75b511f9282c64f18235ed6715a
- Cited by
- 165
- References
- 26
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 4 · 2023: 3 · 2022: 1 · 2021: 8 · 2020: 2 · 2019: 5 · 2018: 7 · 2017: 9 · 2016: 6 · 2015: 8 · 2014: 7 · 2013: 12 · 2012: 5
- FWCI
- 8.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Keywords
- low-dose dexamethasone suppression test, Cushing's syndrome, Cushing's disease, ectopic ACTH syndrome, endogenous hypercortisolism, diagnostic sensitivity, false-negative results, urinary free cortisol, urinary 17-hydroxycorticosteroids, ACTH
- MeSH terms
- Adult, Aged, Cushing Syndrome, Dexamethasone, Glucocorticoids, Humans, Hydrocortisone, Mass Screening, Sensitivity and Specificity, 17-Hydroxycorticosteroids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.